Quotes for FluoGuide A/S
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Morten Albrechtsen
Chairperson of the Board
- Peter Mørch Eriksen
Board
- Andreas Kjaer
- Micaela Sjökvist
- Shomit Ghose
FluoGuide A/S
FluoGuide is a Danish medical technology company. The company focuses on the treatment of cancer, with the greatest focus on the development of products guiding surgery. The products illuminate the cancer cells and are intended to be used for the purpose of being able to remove harmful tumors with precision in the patient's tissue.
News
- Minutes from the Annual General Meeting in FluoGuide A/S
- Spotlight: Market Notice 18/21 – FluoGuide A/S will be delisted after close of the market on February 15, 2021
- Spotlight: Market Notice 17/21 – FluoGuide A/S is moved to the Observation List
- Spotlight: FluoGuide A/S flyttas till Observationslistan för att senare avnoteras från Spotlight/FluoGuide A/S will be transferred to Spotlight Stock Market’s observation list and later delisted
- FluoGuide announces approval for listing on Nasdaq First North Growth Market Sweden on the 24 February 2021
Analysis
- SEB Research: Fluoguide: All’s well that ends well - SEB
- SEB Research: Fluoguide: Q4: FG001 development on track - SEB
- SEB Research: Fluoguide: Green light to proceed to third dose level - SEB
- SEB Research: Fluoguide: FIH data further elucidate equity story - SEB
- SvD Börsplus: Lysande idé för cancerbekämpning
Videos
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Andreas Kjær | 15,61 | 15,61 | 2024-11-27 |
| Morten Albrechtsen | 10,93 | 10,93 | 2024-11-27 |
| Linc AB | 7,21 | 7,21 | 2024-11-27 |